JAMES RUNYON: Open Payments
NPI 1710721402 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 44 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,270 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $248 |
| Janssen Biotech, Inc. | 9 | $141 |
| Arcutis Biotherapeutics, Inc. | 7 | $140 |
| Galderma Laboratories, L.P. | 3 | $77 |
| Lilly USA, LLC | 4 | $75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $53 |
| Amgen Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PFIZER INC. | 1 | $24 |
| Incyte Corporation | 1 | $21 |
Products named: TREMFYA, Zoryve, SKYRIZI, RINVOQ, TALTZ, NEMLUVIO, ILUMYA, OTEZLA.
Industry payments across VA — which companies pay providers there.
